Your search returned 75 studies. (Get alerts for new studies):
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
Conditions: Epilepsies, Partial
Location: Edmond, Oklahoma
- RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure - Anemia - Cardiovascular Disease - Ventricular Dysfunction - Congestive Heart Failure
Location: Oklahoma City, Oklahoma
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Oklahoma City, Oklahoma
- Evaluating the Effectiveness of the LifeVest Defibrillator and Improving Methods for Determining the Use of Implantable Cardioverter Defibrillators
Conditions: Death, Sudden, Cardiac - Myocardial Infarction - Arrhythmias, Cardiac
Location: Oklahoma City, Oklahoma
- Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
Conditions: Alzheimer Disease
Location: Oklahoma City, Oklahoma
- A Study of Pemetrexed, Carboplatin and Bevacizumab in Patients With Nonsquamous Non-Small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer
Location: Oklahoma City, Oklahoma
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
Conditions: Tumor - Ovarian Cancer
Location: Oklahoma City, Oklahoma
- A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage
Conditions: Left Atrial Appendage Occlusion
Location: Oklahoma City, Oklahoma
- Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Oklahoma City, Oklahoma
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Oklahoma City, Oklahoma
- Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer - Metastatic Breast Cancer
Location: Oklahoma City, Oklahoma
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Oklahoma City, Oklahoma
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Oklahoma City, Oklahoma
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Oklahoma City, Oklahoma
- Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
Conditions: Chronic Kidney Disease - Bacterial Infection
Location: Oklahoma City, Oklahoma
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Oklahoma City, Oklahoma
- Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Oklahoma City, Oklahoma
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
Location: Oklahoma City, Oklahoma
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Oklahoma City, Oklahoma
- Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
Conditions: Advanced Heart Failure
Location: Oklahoma City, Oklahoma
- An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lym
Conditions: Neoplasms Malignant
Location: Oklahoma City, Oklahoma
- The Kiva® System as a Vertebral Augmentation Treatment
Conditions: Spinal Fractures - Fractures, Compression - Back Injuries
Location: Edmond, Oklahoma
- Proton Radiotherapy for Recurrent Tumors
Conditions: Tumors
Location: Oklahoma City, Oklahoma
- Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma (NHL)
Location: Oklahoma City, Oklahoma
- Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Conditions: Non-Hodgkin's Lymphoma (NHL)
Location: Oklahoma City, Oklahoma
- A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus - Connective Tissue Disease - Autoimmune Disease
Location: Edmond, Oklahoma
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Oklahoma City, Oklahoma
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Oklahoma City, Oklahoma
- Vitamin D and Breast Cancer Biomarkers in Female Patients
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
Conditions: Hyponatremia - Dilutional Hyponatremia - Inappropriate ADH Syndrome
Location: Oklahoma City, Oklahoma
- Study of Hypo-fractionated Proton Radiation for Prostate Cancer
Conditions: Prostate Cancer
Location: Oklahoma City, Oklahoma
- Registry Study for Proton Therapy Outcomes
Conditions: Solid Tumors
Location: Oklahoma City, Oklahoma
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Melanoma (Skin)
Location: Oklahoma City, Oklahoma
- Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hosp
Conditions: Heart Failure
Location: Oklahoma City, Oklahoma
- A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Conditions: Overactive Bladder
Location: Edmond, Oklahoma
- Efficacy, Safety, and Tolerability of SAR231893(REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves
Conditions: Symptomatic Severe Aortic Stenosis
Location: Oklahoma City, Oklahoma
- A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention
Conditions: Myocardial Infarction
Location: Oklahoma City, Oklahoma
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Oklahoma City, Oklahoma
- A Multiple Dose Study Of PF-04950615 In Subjects On Maximum Doses Of Statins
Conditions: Hypercholesterolemia - Dyslipidemia
Location: Oklahoma City, Oklahoma
- ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer (NSCLC)
Location: Oklahoma City, Oklahoma
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
Conditions: Major Depressive Disorder
Location: Enid, Oklahoma
- Study of Bevacizumab/mFOLFOX6 Versus Bevacizumab/Folfiri With Biomarker Stratification in Patients With Previously Untreated Metastatic Colorectal Can
Conditions: Colorectal Cancer
Location: Oklahoma City, Oklahoma
- A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GAGE)
Conditions: Lymphocytic Leukemia, Chronic
Location: Oklahoma City, Oklahoma
- The OMEGA Clinical Trial
Conditions: Atherosclerosis - Coronary Artery Disease
Location: Oklahoma City, Oklahoma
- An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic
Location: Oklahoma City, Oklahoma
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinu
Conditions: Small Cell Lung Carcinoma
Location: Oklahoma City, Oklahoma
- A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Conditions: Perennial Allergic Rhinitis - PAR
Location: Oklahoma City, Oklahoma
- Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
Conditions: Painful Diabetic Peripheral Neuropathy
Location: Oklahoma City, Oklahoma
- Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Pati
Conditions: Arrhythmias, Cardiac - Heart Diseases - Cardiovascular Diseases - Implantable Cardioverter Defibrillator
Location: Oklahoma City, Oklahoma
- Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN)
Conditions: Diabetic Peripheral Neuropathy
Location: Oklahoma City, Oklahoma
- Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD
Conditions: Primary Immunodeficiency Disorders
Location: Oklahoma City, Oklahoma
- The Effect of Vitamin D Supplementation on Muscle Power in Elite Cyclist
Conditions: Muscle Power
Location: Stillwater, Oklahoma
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Oklahoma City, Oklahoma
- A Study of ARRY-502 in Patients With Persistent Asthma
Conditions: Asthma
Location: Oklahoma City, Oklahoma
- A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Conditions: Asthma
Location: Oklahoma City, Oklahoma
|